Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2024
4 years of board service in total across 2 boards, counting each seat separately. Longest: Zentalis Pharmaceuticals Inc., 2 years.
Zentalis Pharmaceuticals Inc.
Director
Context Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Context Therapeutics Inc. June 24, 2026100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Zentalis Pharmaceuticals Inc. | Grant or award | +57,100 | — | — |
| Jun 17, 2025 | Zentalis Pharmaceuticals Inc. | Grant or award | +57,603 | — | — |
| Jan 31, 2025 | Zentalis Pharmaceuticals Inc. | Open-market purchase | +14,200 | $1.76 | $24,992 |
| May 24, 2024 | Zentalis Pharmaceuticals Inc. | Grant or award | +72,481 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.